RFC
SGYP

Russell Frank Company’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Russell Frank Company’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-214,079
Closed -$1.22M – 3089
2015
Q4 		$1.22M Sell
214,079
-4,211
-2% -$25.7K ﹤0.01% 2111
2015
Q3 		$1.16M Sell
218,290
-54,759
-20% -$424K ﹤0.01% 2133
2015
Q2 		$2.27M Buy
+273,049
New +$1.32M ﹤0.01% 1896
2013
Q4 		– Sell
-435
Closed -$2K – 3211
2013
Q3 		$2K Buy
435
+163
+60% +$731 ﹤0.01% 3370
2013
Q2 		$1K Buy
+272
New +$1.37K ﹤0.01% 3293

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Russell Frank Company's SGYP Position: Q1 2016 in Review

Russell Frank Company sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2016, closing a stake of 214,079 shares — an estimated $1.22M sold.

Russell Frank Company first reported a position in SGYP in Q2 2013 and held it in 5 quarters. The position peaked at $2.27M in Q2 2015. 128 funds tracked by Wall St. Rank hold SGYP as of Q1 2016.

  • Russell Frank Company reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2016 after selling out during the quarter.
  • Russell Frank Company sold 214,079 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2016, an estimated $1.22M.
  • Russell Frank Company first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 5 quarters.
  • Russell Frank Company's Synergy Pharmaceuticals, Inc Common Stock position peaked at $2.27M in Q2 2015.
  • 128 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.